The firm said the first quarter was the best quarter in its history and reiterated its full-year guidance for 2015.
On an adjusted basis and at constant exchange rates, revenues increased 2 percent year over year, led by consumables and instrument revenues across all customer classes.
BGI will provide Qiagen's Ingenuity Variant Analysis software in integrated bioinformatics for all customers of its sequencing services.
The firm, HalioDx, was formed following the departure of Qiagen Marseille's executive team and all its employees.
The firms expanded their deal to develop a companion test for galeterone based on circulating tumor cell technology Qiagen has acquired from AdnaGen.
Transgenomic has gained the rights to use Exiqon's locked nucleic acid oligonucleotides for several platforms, including NGS and ICE COLD-PCR.
The firm landed Enzymatics' enzyme solutions unit in the December 2014 acquisition. It also plans to repurchase outstanding convertible notes.
Thirteen institutions and life sciences companies have teamed up to launch the free repository that will offer access to allele frequency information from genomes and exomes.
The Danish miRNA firm reported record sales of products and services, and narrowed its net loss for 2014.
In the fourth quarter Qiagen posted revenues of $360.4 million compared to $361.1 million in Q4 2013, and short of the Wall Street estimate of $367.7 million.
Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.
St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.
St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.
In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.